Receptor activator of nuclear factor κB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening

被引:42
作者
Gehrke, T
Sers, C
Morawietz, L
Fernahl, G
Neidel, J
Frommelt, L
Krenn, V
机构
[1] ENDO Klin Hamburg, Hamburg, Germany
[2] Univ Clin Charite, Inst Pathol, Berlin, Germany
[3] Univ Clin Charite, Dept Orthopaed, Berlin, Germany
关键词
RANKL; RANK; OPG; septic loosening; aseptic loosening; endoprosthesis; DEBRIS-INDUCED OSTEOLYSIS; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; GENE-THERAPY; TOTAL HIP; T-CELLS; REPLACEMENTS; MACROPHAGES; CYTOKINE;
D O I
10.1080/03009740310003929
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The pathogenesis of periprosthetic bone loss in aseptic and septic prosthesis loosening is unclear. There is considerable evidence that macrophages and osteoclasts play a key role in focal bone erosion and osteolysis around the prosthesis. RANKL (receptor activator of nuclear factor kappaB ligand) was shown to be a potent osteoclastogenic factor, and to be involved in bone destruction of myeloma and rheumatoid arthritis patients. Osteoprotegerin (OPG) is the natural RANKL inhibitor and may prevent periprosthetic bone loss. Methods: The presence and distribution of RANKL, its receptor RANK and OPG in the periprosthetic interface of septically (n=5) and aseptically (n=6) loosened prostheses was examined by immunohistochemistry and immunoblotting. Additionally, the immunophenotype of the inflammatory infiltrate was determined [CD3, CD68, Ki-67, tartrate-resistant acid posphatase (TRAP)]. Results: Aseptic and septic cases revealed a different histopathologic pattern. However, in all cases RANKL and RANK could be demonstrated in macrophages and giant cells. In addition, RANKL detected by immunoblot analysis proved to have the same molecular weight as a recombinant RANKL used as a control (31 kappaD and approximately 48 kappaD). OPG was detected in aseptic loosening, where macrophages showed a strong staining, but multinucleated giant cells were only weakly stained. A weak OPG staining was also observed in septic loosening. Conclusion: The pathogenesis of bone loss in septic loosening remains unclear, because the septic membrane bears few macrophages and giant cells, and half of them express OPG. In aseptic loosening, macrophages might not be stimulated by RANKL as a result of OPG expression. But multinucleated giant cells may be activated, as they hardly express OPG. They might be responsible for periprosthetic bone loss in aseptic loosening as a result of their RANKL and RANK expression.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 32 条
[21]   Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival [J].
Lum, L ;
Wong, BR ;
Josien, R ;
Becherer, JD ;
Erdjument-Bromage, H ;
Schlöndorff, J ;
Tempst, P ;
Choi, Y ;
Blobel, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13613-13618
[22]   TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis [J].
Pettit, AR ;
Ji, H ;
von Stechow, D ;
Müller, R ;
Goldring, SR ;
Choi, YW ;
Benoist, C ;
Gravallese, EM .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05) :1689-1699
[23]   Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells [J].
Sabokbar, A ;
Fujikawa, Y ;
Neale, S ;
Murray, DW ;
Athanasou, NA .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (07) :414-420
[24]   Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells [J].
Sakai, H ;
Jingushi, S ;
Shuto, T ;
Urabe, K ;
Ikenoue, T ;
Okazaki, K ;
Kukita, T ;
Kukita, A ;
Iwamoto, Y .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (02) :103-109
[25]   Human bone marrow myeloma cells express RANKL [J].
Sezer, O ;
Heider, U ;
Jakob, C ;
Eucker, J ;
Possinger, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :353-354
[26]   RANK-Fc: A therapeutic antagonist for RANK-L in myeloma [J].
Sordillo, EM ;
Pearse, RN .
CANCER, 2003, 97 (03) :802-812
[27]  
Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO
[28]  
2-W
[29]  
Tucci M, 1999, Biomed Sci Instrum, V35, P223
[30]   Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis [J].
Ulrich-Vinther, M ;
Carmody, EE ;
Goater, JJ ;
Soballe, K ;
O'Keefe, RJ ;
Schwarz, EM .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (08) :1405-1412